Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NPY5R ELISA Kit (AC2854)
Cat.#: ASET-1443
Specifications
Description Human NPY5R ELISA Kit allows for the in vitro quantitative determination of human NPY5R concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2301 Human Granulin ELISA Kit (AC3712) Quantitative inquiry ASET-1410 Goat Insulin ELISA Kit (AC2821) Quantitative inquiry ASET-1101 Human RDH11 ELISA Kit (AC2512) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-1211 Goat IL-6 ELISA Kit (AC2622) Quantitative inquiry ASET-2532 Rabbit beta Nerve Growth Factor ELISA Kit (AC3943) Quantitative inquiry ASET-1668 Rat SIRP alpha ELISA Kit (AC3079) Quantitative inquiry ASET-1905 Human Myelin Basic Protein ELISA Kit (AC3316) Quantitative inquiry ASET-1361 Sheep Inhibin beta B ELISA Kit (AC2772) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket